Oxidative Stress in Rats after 60 Days of Hypergalactosemia or Hyperglycemia

International Journal of Toxicology

Volumn 22, Issue 6, 2003, Pages 423-427

  Otsyula, Mary ^a   King, Matthew S ^b   Ketcham, Tonya G ^b   Sanders, Ruth A ^b   Watkins III, John B ^b  

^a MOI UNIVERSITY   (Kenya)

^b Indiana University School of Medicine   (United States)

Author keywords

Diabetes; Galactose; Glucose; Heart; Kidney; Liver

Indexed keywords

BIOLOGICAL MARKER; CATALASE; GALACTOSE; GLUCOSE; GLUTATHIONE; GLUTATHIONE DISULFIDE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; HUMAN INSULIN; MALONALDEHYDE; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; ENZYME ACTIVITY; GALACTOSEMIA; GLUCOSE BLOOD LEVEL; HEART; HYPERGLYCEMIA; KIDNEY; LIPID PEROXIDATION; LIVER; NONHUMAN; OXIDATIVE STRESS; RAT; STREPTOZOCIN DIABETES;

ANIMALIA; VERTEBRATA;

EID: 0347087358     PISSN: 10915818     EISSN: None     Source Type: Journal    
DOI: 10.1177/109158180302200603     Document Type: Article

References (41)

1. Baynes, J. W. 1991. Role of oxidative stress in development of complications in diabetes. Diabetes 40:405-412.
2. Baynes, J. W. 1999. Role of oxidative stress in diabetic complications: A new perspective on an old paradigm. Diabetes 48:1-9.
3. Berry, G. T. 1995. The role of polyols in the pathophysiology of hypergalactosemia. Eur. J. Pediatr. 154:S53-S64.
4. Bohles, H., J. Schadle, W. Endres, Y. S. Shin, F. Kollmann, S. W. Bender, and K. Kruse. 1987. Increased concentrations of HbAlab in hereditary fructose intolerance and galactosemia. Padiatr. Padol. 22:25-31.
5. Calcutt, N. A., D. R. Tomlinson, and S. Biswas. 1990. Coexistence of nerve conduction deficit with increased Na(+)-K(+)-ATPase activity in galactose-fed mice. Implications for polyol pathway and diabetic neuropathy. Diabetes 39:663-666.
6. Carlberg, I., and B. Mannervik. 1975. Purification and characterization of the flavoenzyme glutathione reductase from rat liver. J. Biol. Chem. 250:5475-5480.
7. Chari, S. N., N. Nath, and A. B. Rathi. 1984. Glutathione and its redox system in diabetic polymorphonuclear leukocytes. Am. J. Med. Sci. 287:14-15.
8. Cotter, M. A., N. E. Cameron, and S. Robertson. 1992. Polyol pathway-mediated changes in cardiac muscle contractile properties: Studies in streptozotocin-diabetic and galactose-fed rats. Exp. Physiol. 77:829-838.
9. Crapo, J. D., J. M. McCord, and I. Fridovich. 1978. Preparation and assay of superoxide dismutases. Methods Enzymol. 53:382-393.
10. Engerman, R. L., and T. S. Kern. 1984. Experimental galactosemia produces diabetic-like retinopathy. Diabetes 33:97-100.
11. Engerman, R. L., T. S. Kern, and M. E. Larson. 1994. Nerve conduction and aldose reductase inhibition during 5 years of diabetes or galactosaemia in dogs. Diabetologia 37:141-144.
12. Frank, R. N., S. Dutta, and S. E. Frank. 1987. Cerebral cortical capillary basement membrane thickening in galactosaemic rats. Diabetologia 30:739-744.
13. Gerken, K. L., and F. Van Lente. 1990. Effectiveness of screening for diabetes. Arch. Pathol. Lab. Med. 114:201-203.
14. Hissin, P. J., and R. Hilf. 1976. A fluorometric method for determination of oxidized and reduced glutathione in tissues. Anal. Biochem. 74:214-226.
15. Hunt, J. V., R. T. Dean, and S. P. Wolff. 1988. Hydroxyl radical production and autoxidative glycosylation. Glucose autoxidation as the cause of protein damage in the experimental glycation model of diabetes mellitus and ageing. Biochem. J. 256:205-212.
16. Kakkar, R., S. V. Mantha, J. Kalra, and K. Prasad. 1996. Time course study of oxidative stress in aorta and heart of diabetic rat. Clin. Sci. 91:441-448.
17. Kern, T. S., and R. L. Engerman. 1987. Kidney morphology in experimental hyperglycemia. Diabetes 36:244-249.
18. Kern, T. S., and R. L. Engerman. 1994. Comparison of retinal lesions in alloxan-diabetic rats and galactose-fed rats. Curr. Eye Res. 13:863-867.
19. Kern, T. S., R. A. Kowluru, and R. L. Engerman. 1994. Abnormalities of retinal metabolism in diabetes or galactosemia: ATPases and glutathione. Invest. Ophthalmol. Vis. Sci. 35:2962-2967.
20. Kern, T. S., J. Tang, M. Mizutani, R. A. Kowluru, R. H. Nagaraj, G. Romeo, F. Podesta, and M. Lorenzi. 2000. Response of capillary cell death to aminoguanidine predicts the development of retinopathy: Comparison of diabetes and galactosemia. Invest. Ophthalmol. Vis. Sci. 41:3972-3978.
21. Kinoshita, J. H. 1965. Cataracts in galactosemia. The Jonas S. Friedenwald Memorial Lecture. Invest. Ophthalmol. 4:786-799.
22. Kowluru, R. A., R. L. Engerman, and T. S. Kern. 2000a. Abnormalities of retinal metabolism in diabetes or experimental galactosemia. VIII. Prevention by aminoguanidine. Curr. Eye Res. 21:814-819.
23. Kowluru, R. A., R. L. Engerman, and T. S. Kern. 2000b. Diabetes-induced metabolic abnormalities in myocardium: Effect of antioxidant therapy. Free Radic. Res. 32:67-74.
24. Kowluru, R. A., T. S. Kern, R. L. Engerman, and D. Armstrong. 1996. Abnormalities of retinal metabolism in diabetes or experimental galactosemia. III. Effects of antioxidants. Diabetes 45:1233-1237.
25. Lorentz, W. B., Z. K. Shihabi, and N. Weidner. 1987. Galactosemic nephropathy in the rat. Clin. Physiol. Biochem. 5:261-267.
26. Lou, M. F., J. E. Dickerson, Jr., M. L. Chandler, R. K. Brazzell, and B. M. York, Jr. 1989. The prevention of biochemical changes in lens, retina, and nerve of galactosemic dogs by the aldose reductase inhibitor AL01576. J. Ocul. Pharmacol. 5:233-240.
27. Lowry, O., N. J. Rosebrough, A. L. Farr, and R. J. Randall. 1951. Protein measurements with Folin phenol reagent. J. Biol. Chem. 193:265-275.
28. Luck, H. 1963. Catalase. In Methods of Enzymatic Analysis, ed. H.-U. Bergmeyer, 885-888. New York: Academic Press.
29. Mekinova, D., V. Chorvathova, K. Volkovova, M. Staruchova, E. Grancicova, J. Klvanova, and R. Ondreicka. 1995. Effect of intake of exogenous vitamins C, E and β-carotene on the antioxidative status in kidneys of rats with streptozotocin-induced diabetes. Nahrung 39:257-261.
30. Nath, N., S. N. Chari, and A. B. Rathi. 1984. Superoxide dismutase in diabetic polymorphonuclear leukocytes. Diabetes 33:586-589.
31. National Research Council. 1996. Guide for the care and use of laboratory animals. Washington DC: National Academy Press.
32. Ohkawa, H., N. Ohishi, and K. Yagi. 1979. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal. Biochem. 95:351-358.
33. Rauscher, F. M., R. A. Sanders, and J. B. Watkins, 3rd. 2000. Effects of new antioxidant compounds PNU-104067F and PNU-74389G on antioxidant defense in normal and diabetic rats. J. Biochem. Mol. Toxicol. 14:189-194.
34. Rauscher, F. M., R. A. Sanders, and J. B. Watkins, 3rd. 2001. Effects of isoeugenol on oxidative stress pathways in normal and streptozotocin-induced diabetic rats. J. Biochem. Mol. Toxicol. 15:159-164.
35. Robison, W. G., and N. Laver. 1993. Ocular lesions in animal models of human diabetes. In Frontiers in diabetic research, lessons from animal diabetes, ed. E. Shafrir, 145-163. London: Smith-Gordon and Co. Ltd.
36. Strother, R. M., T. G. Thomas, M. Otsyula, R. A. Sanders, and J. B. Watkins, 3rd. 2001. Characterization of oxidative stress in various tissues of diabetic and galactose-fed rats. Int. J. Exp. Diabetes Res. 2:211-216.
37. Tappel, A. L. 1978. Glutathione peroxidase and hydroperoxides. Methods Enzymol. 52:506-513.
38. Toleikis, P. M., and D. V. Godin. 1995. Alteration of antioxidant status in diabetic rats by chronic exposure to psychological stressors. Pharmacol. Biochem. Behav. 52:355-366.
39. Volkovova, K., V. Chorvathova, M. Jurcovicova, L. Koszeghyova, and P. Bobek. 1993. Antioxidative state of the myocardium and kidneys in acute diabetic rats. Physiol. Res. 42:251-255.
40. Willars, G. B., J. E. Lambourne, and D. R. Tomlinson. 1987. Does galactose feeding provide a valid model of consequences of exaggerated polyol-pathway flux in peripheral nerve in experimental diabetes? Diabetes 36:1425-1431.
41. Wolff, S. P., and R. T. Dean. 1987. Glucose autoxidation and protein modification. The potential role of 'autoxidative glycosylation' in diabetes. Biochem. J. 245:243-250.